← Current Affairs
Daily · 9 November 2026

Dr Jitendra Singh reviews progress of the cannabis medicinal research project at CSIR-IIIM, Jammu

SSCRailwayScienceGeneral

Union Minister of State (Independent Charge) for Science and Technology Dr Jitendra Singh reviewed the progress of the Cannabis Medicinal Research Project at the CSIR-Indian Institute of Integrative Medicine (IIIM), Jammu, on 9 November 2026, with a particular focus on its potential medical applications, the Ministry of Science and Technology said. Describing it as India's first-of-its-kind cannabis research project, the Minister said it is expected to pave the way for the development of export-quality medicines for neuropathies, cancer, epilepsy and Acute Respiratory Distress Syndrome (ARDS), and that cannabis is sought to be developed as export-quality painkillers. He said the project has been undertaken through a Public-Private Partnership (PPP) model with the participation of a French company, is aimed exclusively at exploring the medicinal and life-science applications of cannabis, and that appropriate regulatory provisions have been put in place to ensure its cultivation and use strictly for scientific research and medical purposes. According to the Minister, the project is now moving towards pre-clinical trials, for which engagement has been established with Tata Memorial Centre, Mumbai, and after successful pre-clinical studies and the requisite regulatory processes it would move towards drug production; he said the initiative holds considerable potential to deliver both economic and medicinal dividends. Dr Zabeer Ahmed, Director, CSIR-IIIM and CSIR-NBRI, Lucknow, briefed the Minister on progress in identifying potential cannabis-based drug candidates and said the institute had applied to the J&K Excise Department for permission for GMP-compliant manufacturing and transportation of cannabis material exclusively for scientific purposes. The release says the project received permission from the Jammu and Kashmir Government in 2017 for scientific cultivation and research, and that CSIR-IIIM has established protected cultivation facilities and a repository of more than 500 cannabis accessions.

Drafted with AI assistance from the official PIB release linked above and checked against it by a second AI pass. Not line-edited by a human. Published by Mahesh Srivastava, who corrects any error you report.

Learning context

Dr Jitendra Singh had visited the project's cultivation farm in 2023. According to a Ministry of Science and Technology release of 23 July 2023, he visited the Cannabis Cultivation Farm of CSIR-IIIM at Chatha near Jammu, where the institute was doing large-scale cultivation of superior accessions of cannabis in a one-acre protected area and had glass houses with climate control facilities for research on improving varieties for desired cannabinoid content. That release described the project as being in Private Public Partnership with a Canadian firm and referred to the signing of a scientific agreement between CSIR-IIIM and IndusScan. Director Dr Zabeer Ahmed told the Minister that CSIR-IIIM had a repository of more than 500 accessions collected from different parts of the country, and that under a tripartite agreement of CSIR with the Department of Biotechnology (DBT) and the Indian Council of Medical Research (ICMR) it had completed exploratory research after the J&K Government granted a licence for cultivation for scientific purposes; an application to the J&K Excise Department for GMP manufacturing and transportation was then still under process. The release said CSIR-IIIM obtained the first licence for cannabis cultivation in the country, after which states such as Uttarakhand, Uttar Pradesh, Manipur, Madhya Pradesh and Himachal Pradesh started making policy and rules for the use of cannabis for scientific purposes.

Reference: PIB (Ministry of Science and Technology), 'Dr. Jitendra Singh visits Cannabis Cultivation Field of CSIR-IIIM at its Chatha Farm', 23 July 2023

Check yourself: according to the July 2023 release, where is CSIR-IIIM's cannabis cultivation farm, and how many accessions did its repository hold?

At Chatha near Jammu; more than 500 accessions collected from different parts of the country.

Revision task: from this release, note the institute and city, the Minister's post, the diseases for which medicines are sought, the partnership model, the institution engaged for pre-clinical trials, the permission the institute has applied for and to whom, the year of the J&K Government's permission and the size of the repository; from the note, where the cultivation farm is and the institutions in the tripartite agreement. Remember that 'first-of-its-kind' and the expected export-quality medicines and dividends are the Minister's statements, and that the 2023 release named a Canadian partner while this one refers to a French company.

Test yourself

According to Dr Jitendra Singh, with which institution has engagement been established for the pre-clinical trials of the cannabis medicinal research project of CSIR-IIIM, Jammu?

  1. Tata Memorial Centre, Mumbai
  2. AIIMS, New Delhi
  3. PGIMER, Chandigarh
  4. Christian Medical College, Vellore
Show the answer

Answer: Tata Memorial Centre, Mumbai

Dr Jitendra Singh said the project is now moving towards pre-clinical trials, for which engagement has been established with Tata Memorial Centre, Mumbai, and that after successful pre-clinical studies and the requisite regulatory processes it would move towards drug production. The project received permission from the Jammu and Kashmir Government in 2017 for scientific cultivation and research.

Report this question

Read the daily collection → · Editorial standards & corrections